openPR Logo
Press release

Opioids Market - Positive long-term growth outlook 2025

08-14-2017 12:50 PM CET | Health & Medicine

Press release from: Transparency Market Research

Opioids Market

Opioids Market

Opioids are the most widely prescribed medications to treat moderate to severe chronic pain. These analgesics are used to manage pain in cancer patients and also to treat severe constant pain in patients suffering from terminal illnesses. These are generally administered via subcutaneous, oral and intramuscular routes; other routes of administration include nasal insufflations, patient controlled analgesia, transdermal and oral mucosa routes via lozenges. Opioids can be classified into three major classes namely, strong agonists (fentanyl, oxymorphone, and morphine), mild to moderate agonists (codeine and hydroxycodone), and opioids with mixed receptor reactions (buprenophrine and pentazocine). Although they form one of the most widely used analgesic classes, they cause certain adverse effects such as constipation, nausea, vomiting, sedation, respiratory depression and others. However, the major concern with this drug class is the high level of drug abuse observed worldwide, leading to illegal trade of these drugs worth hundreds of billions of dollars. According to a study published in the Journal of American Medical Association in April 2011, the rate of deaths occurring due to the overdose of prescription opioids has increased substantially in the last decade in the U.S. alone. This study also indicated that high doses of opioid drugs prescribed for pain management possessed increased risk of overdose mortality in the patients.

This report gives readers a comprehensive overview of the Opioids Market: http://www.transparencymarketresearch.com/opioids-market.html

The leading molecules in this segment that constituted about 65% of the total opioids market include OxyContin (oxycodone), Nucynta (tapentadol), Rybix and Ultram (tramadol), Exalgo (hydromorphone), Ultiva (remifentanil) and fentanyl.The remaining 35% market revenue was contributed by other generic opioids as well as combination formulations of NSAIDs with opioids.The actual market scenario for this drug class, however, could be different due to the strong product pipeline, with two major entries MoxDuo IR (morphine/oxycodone) and Remoxy (oxycodone) set to hit the market in 2016. The market entry of these two drugs is expected to boost growth of the overall opioids market during the forecast period. The number of patients suffering from chronic pain is on a constant rise globally. Thus, increasing incidence of chronic pain conditions will continue to encourage the use of pain management drugs, thereby driving the opioids market. Doctors usually prescribe medicines in the initial stages of pain, followed by other treatment options. Prescription drugs are easy to use and economical and are expected to support the growth of the opioids market globally. Prescription drug abuse is the major factor which will limit the growth of the global opioids market.

The global opioids market has been segmented by type, geography, and distribution channel. The market by type includes endogenous (enkephalins, endorphins), opium alkaloids, and synthetic and semisynthetic opioids. The market for semisynthetic and synthetic opioids like fentanyl and oxycodone are expected to grow during the forecast period due to their fast and potent analgesic activity. Based on distribution channels, the global opioids market has been divided into retail pharmacies, hospital pharmacies, and online pharmacies. The hospital pharmacy segment is expected to support the growth of the global opioids market due to high demand for pain killers in hospitals globally.

Get accurate market forecast and analysis on the Opioids Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22928

Based on geographic segmentation, the global opioids market is segmented into five key regions: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. According to the U.S. Institute of Medicine, approximately 100 million adults suffered from common chronic conditions such as low back pain followed by migraine and neck pain. North America is expected to be a major contributor to the global opioids market since it has the maximum percentage of population suffering from pain. Europe follows closely due to high prevalence rate of various diseases such as orthopedic and cancer. India, China, and Japan are the most developing countries in Asia Pacific and hence fuel the growth of the global opioids market.

The major players active in the global opioids market includes Purdue Pharma, Pfizer, Inc., QRxpharma limited, Endo Pharmaceuticals Inc., Johnson & Johnson Services, Inc., Mylan N.V., and AbbVie Inc.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Opioids Market - Positive long-term growth outlook 2025 here

News-ID: 667972 • Views: 105

More Releases from Transparency Market Research

Impact of Outbreak of COVID-19 on Medical Education Market : Global Industry Ana …
Transparency Market Research (TMR) has published a new report on the medical education market for the period of 2019–2027. According to the report, the global medical education market was valued at nearly US$ 31 Bn in 2018, and is projected to expand at a CAGR of more than 4% from 2019 to 2027. Rise in the number of medical schools and increase in cost of medical education are the
Healthcare BI Platform Market Companies Analysis, Advancement and Precise Outloo …
In an intensely competitive healthcare business intelligence (BI) platform market, large players are aggressively focused on expanding their geographical outreach, says Transparency Market Research (TMR) in a new market intelligence report. These large players are leveraging the cloud business model to provide healthcare BI solutions that can be accessed irrespective of location. Apart from this, savvy players are entering into partnerships with hospital groups and healthcare bodies to integrate healthcare BI
Substance Abuse Treatment Market News Research Report 2024
A recent report by Transparency Market Research on the substance abuse treatment market in the U.S. states that the competitive landscape is highly fragmented. This is because around 242 companies compete against one another in it. This also makes overall competition stiff. Some of the companies that have beat competition to emerge as leading players in the market are Pfizer Inc., Alkermes Plc, GlaxoSmithKline Plc., and Purdue Pharma LP. Their
Clinical Oncology Next Generation Sequencing Market is Thriving Worldwide By Siz …
Clinical Oncology Next Generation Sequencing: Introduction Next generation sequencing for tumor and germline DNA is required for oncology screening for therapeutic application. Rise in burden of cancer increases the need for early detection of the condition to carry out the generate target therapy. Companies are investing to develop technologically advanced devices/solutions for precision detection. In 2012, Oxford Nanopore had launched the GridION sequencing platform, which can sequence a human genome in 15

All 5 Releases


More Releases for Opioids

Global Opioids Market Research Report
This report studies the global Opioids market status and forecast, categorizes the global Opioids market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Purdue Pharma L.P. West-Ward Pharmaceuticals Corporation Allergan Pfizer, Inc. Janssen Pharmaceuticals, Inc. Egalet Corporation Sun Pharmaceutical Industries Limited. Geographically,
Opioids Market Size, Share | Industry Report 2026
The Opioids Market was valued at $xx.7Billion in 2018 and is forecast to grow at a modestxx.8 % CAGR between2018 and 2025, culminating in 2026 global sales of $xx.8Billion. An Opioids is a class of drugs or medicine which are used in a human body through the nervous system to produce feelings of pleasure or to control the pain after the surgery. It is illegal if you don’t have any
Opioids Market - Technical Innovations & Future Market Trends
An opioid is a form of narcotic pain medication that is utilized to treat moderate to severe pain. The opioids are used as diarrhea suppressant, anesthetic, cough suppressant, and to decrease surgical pain, pain arising from disease, cancer pain and injury or trauma. These substances are majorly utilized in cancer pain management as well as end-stage diseases in which palliative care is needed. However, these opioids can be addictive
Opioids Market Trends and Forecast till 2025
Global Opioids Market, by Drug Class (Agonist (Codeine, Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone, Diphenoxylate, Hydromorphone, Methylphenidate, Oxycodone, Oxymorphone) and Antagonist (Buprenorphine, Naloxone, Naltrexone, Methylnaltrexone, Nalbuphine)), by Therapeutic Application (Pain Management, Cough Treatment, Diarrhea Treatment), and by Geography (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa) was valued at US$ 28,252.3 million in 2016 and is expected to witness a CAGR of 5.3% over the forecast period (2017 - 2025), as highlighted in a new report
Opioids Market Research Report Forecast to 2025
Opioids are the most widely prescribed medications to treat moderate to severe chronic pain. These analgesics are used to manage pain in cancer patients and also to treat severe constant pain in patients suffering from terminal illnesses. These are generally administered via subcutaneous, oral and intramuscular routes; other routes of administration include nasal insufflations, patient controlled analgesia, transdermal and oral mucosa routes via lozenges. Opioids can be classified into three
Global Opioids Drugs Market Research Report 2017
Global Opioids Drug Industry 2017 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2017-2020. The cumulative effect of diverse factors has been responsible behind the stability of the global Opioids Drug market. While there are a few factors creating hindrances for the market, overall the stability is expected to remain intact through the course of the forecast period between 2017 and 2021.